{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T11:28:39Z","timestamp":1769945319365,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:00:00Z","timestamp":1604361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:00:00Z","timestamp":1604361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Autoimmun Highlights"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Marfan syndrome, G6PD deficiency, systemic lupus erythematosus (SLE), and Castleman disease are four distinctive, thoroughly investigated entities whose coincidence was never reported. However, occurrence in pairs was sporadically mentioned in literature.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report a 15-year-old Caucasian G6PD deficient Marfan male patient, who presented with tonic\u2013clonic seizures, fever, a hemolytic episode, and general symptoms. After the discovery of hepatosplenomegaly, malar rash, and painless lymphadenopathy, further testing diagnosed a multifocal Castleman disease of the hyaline vascular subtype and systemic lupus erythematosus with lupus nephritis that got 35 points on the 2019 EULAR\/ACR criteria. G6PD deficiency, SLE &amp; Castleman disease, and seizures were handled medically with eventual improvement in the patient\u2019s condition.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Discussion and conclusion<\/jats:title>\n                <jats:p>It is extremely rare to discover the gathering of these four diseases in the same patient. Marfan syndrome and G6PD deficiency were proven by respective clinical and laboratory examinations. Castleman disease that tends to occur in older age groups was confirmed via pathological study of a lymph node biopsy, which was compatible with the HHV-8 negative type reported in Asian countries. SLE is part of the differential diagnosis for Castleman disease, yet the newest evidence strongly supports its presence as a distinct entity. However, no concrete proof is available to suggest a causative relationship between the four of them, rather than a coincidental occurrence.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13317-020-00138-w","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T18:02:55Z","timestamp":1604426575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Castleman disease and SLE in a G6PD-deficient Marfan patient: a case report and literature review"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2646-3308","authenticated-orcid":false,"given":"Sami","family":"Alhoulaiby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Okar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haya","family":"Samaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisham","family":"Qalaani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,3]]},"reference":[{"key":"138_CR1","volume-title":"Overview of the clinical manifestations of systemic lupus erythematosus in adults","author":"DD Gladman","year":"2019","unstructured":"Gladman DD. Overview of the clinical manifestations of systemic lupus erythematosus in adults. Waltham: Uptodate; 2019."},{"issue":"12","key":"138_CR2","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1182\/blood-2016-10-746933","volume":"129","author":"DC Fajgenbaum","year":"2017","unstructured":"Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G, et al. International, evidence-based consensus diagnostic criteria for HHV-8-negative\/idiopathic multicentric Castleman disease. Blood. 2017;129(12):1646\u201357.","journal-title":"Blood"},{"issue":"8","key":"138_CR3","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0344-0338(97)80015-5","volume":"193","author":"M Kojima","year":"1997","unstructured":"Kojima M, Nakamura S, Itoh H, Yoshida K, Asano S, Yamane N, et al. Systemic lupus erythematosus (SLE) lymphadenopathy presenting with histopathologic features of Castleman\u2019 disease: a clinicopathologic study of five cases. Pathol Res Pract. 1997;193(8):565\u201371.","journal-title":"Pathol Res Pract"},{"issue":"1","key":"138_CR4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1001\/archderm.1979.04010010040011","volume":"115","author":"AJ Aronson","year":"1979","unstructured":"Aronson AJ, Soltani K, Aronson IK, Ong RT. Systemic lupus erythematosus and dermatitis herpetiformis: concurrence with Marfan\u2019s syndrome. Arch Dermatol. 1979;115(1):68\u201370.","journal-title":"Arch Dermatol"},{"issue":"11","key":"138_CR5","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.2169\/naika.74.1573","volume":"74","author":"M Tauchi","year":"1985","unstructured":"Tauchi M, Yasuma M, Hashimoto H, Hirose S. The coexistence of rheumatoid arthritis and systemic lupus erythematosus accompanied with Marfan syndrome (forme fruste) in two sisters. Nippon Naika Gakkai Zasshi. 1985;74(11):1573\u20138.","journal-title":"Nippon Naika Gakkai Zasshi"},{"issue":"2","key":"138_CR6","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1378\/chest.06-1346","volume":"131","author":"TT Pham","year":"2007","unstructured":"Pham TT, Harrell JH, Harrell JH, Herndier B, Yi ES. Endotracheal castleman disease: a case report. Chest. 2007;131(2):590\u20132.","journal-title":"Chest"},{"issue":"3","key":"138_CR7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/acr.23296","volume":"70","author":"S Mohammad","year":"2018","unstructured":"Mohammad S, Clowse MEB, Eudy AM, Criscione-Schreiber LG. Examination of hydroxychloroquine use and hemolytic anemia in G6PDH-deficient patients. Arthritis Care Res (Hoboken). 2018;70(3):481\u20135.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"138_CR8","first-page":"543","volume":"38","author":"L Zhang","year":"2016","unstructured":"Zhang L, Cao X-X, Wang S-J, Zhou D-B, Li J. Clinical features of patients with Castleman\u2019s disease complicated systemic lupus erythematosus. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2016;38(5):543\u20137.","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"issue":"7","key":"138_CR9","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1007\/s00296-010-1451-0","volume":"32","author":"J-Y Xia","year":"2012","unstructured":"Xia J-Y, Chen X-Y, Xu F, Yang Y, Wang H-Y, Xue J. A case report of systemic lupus erythematosus combined with Castleman\u2019s disease and literature review. Rheumatol Int. 2012;32(7):2189\u201393.","journal-title":"Rheumatol Int"},{"issue":"3","key":"138_CR10","first-page":"265","volume":"11","author":"S Shariatpanahi","year":"2016","unstructured":"Shariatpanahi S, Pourfarzam S, Gheini M. Association of macrophage activating syndrome with Castleman\u2019s syndrome in systemic lupus erythematosus. Iran J Pathol. 2016;11(3):265\u201371.","journal-title":"Iran J Pathol"},{"issue":"8","key":"138_CR11","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/S0022-3468(86)80385-2","volume":"21","author":"RW Powell","year":"1986","unstructured":"Powell RW, Lightsey AL, Thomas WJ, Marsh WL. Castleman\u2019s disease in children. J Pediatr Surg. 1986;21(8):678\u201382.","journal-title":"J Pediatr Surg"},{"key":"138_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/107327481402100403","volume":"21","author":"JD Soumerai","year":"2014","unstructured":"Soumerai JD, Sohani AR, Abramson JS. Diagnosis and management of Castleman disease. Cancer Control. 2014;21:12.","journal-title":"Cancer Control"},{"issue":"9","key":"138_CR13","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","volume":"78","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European league against rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"138_CR14","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/BOR.0b013e32834db525","volume":"24","author":"TW Muskardin","year":"2012","unstructured":"Muskardin TW, Peterson BA, Molitor JA. Castleman disease and associated autoimmune disease. Curr Opin Rheumatol. 2012;24(1):76\u201383.","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"138_CR15","first-page":"42","volume":"34","author":"S Hosaka","year":"1994","unstructured":"Hosaka S, Kondo H. Three cases of Castleman\u2019s disease mimicking the features of collagen disease. Ryumachi. 1994;34(1):42\u20137.","journal-title":"Ryumachi"},{"issue":"12","key":"138_CR16","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1136\/ard.2010.130476","volume":"69","author":"GK Bertsias","year":"2010","unstructured":"Bertsias GK, Ioannidis JPA, Aringer M, Bollen E, Bombardieri S, Bruce IN, et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis. 2010;69(12):2074\u201382.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"138_CR17","first-page":"101","volume":"72","author":"A Rezgui","year":"2017","unstructured":"Rezgui A, Ghannouchi N, Gabbouj A, Anoun J, Karmani M, Mzabi A, et al. Seizures in patients with systemic lupus erythematosus. Rev Med Liege. 2017;72(2):101\u20135.","journal-title":"Rev Med Liege"},{"issue":"1","key":"138_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2176\/nmc.45.59","volume":"45","author":"K Matsumura","year":"2005","unstructured":"Matsumura K, Nakasu S, Tanaka T, Nioka H, Matsuda M. Intracranial localized Castleman\u2019s disease. Case report. Neurol Med Chir (Tokyo). 2005;45(1):59\u2013655.","journal-title":"Neurol Med Chir (Tokyo)"},{"issue":"2","key":"138_CR19","first-page":"53","volume":"92","author":"S Goenka","year":"1999","unstructured":"Goenka S, Mehta AV. Petit mal seizure in a child with Marfan\u2019s syndrome. Tenn Med. 1999;92(2):53\u20134.","journal-title":"Tenn Med"},{"issue":"1","key":"138_CR20","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1528-1157.1983.tb04865.x","volume":"24","author":"NS Chu","year":"1983","unstructured":"Chu NS. Marfan\u2019s syndrome and epilepsy: report of two cases and review of the literature. Epilepsia. 1983;24(1):49\u201355.","journal-title":"Epilepsia"},{"issue":"1","key":"138_CR21","doi-asserted-by":"publisher","first-page":"5266","DOI":"10.4081\/hr.2014.5266","volume":"6","author":"A Merdin","year":"2014","unstructured":"Merdin A, Avci F, Guzelay N. Glucose-6-phosphate dehydrogenase deficiency presented with convulsion: a rare case. Hematol Rep. 2014;6(1):5266.","journal-title":"Hematol Rep"}],"container-title":["Autoimmunity Highlights"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13317-020-00138-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13317-020-00138-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13317-020-00138-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T02:03:22Z","timestamp":1604714602000},"score":1,"resource":{"primary":{"URL":"https:\/\/autoimmunhighlights.biomedcentral.com\/articles\/10.1186\/s13317-020-00138-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,3]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["138"],"URL":"https:\/\/doi.org\/10.1186\/s13317-020-00138-w","relation":{},"ISSN":["2038-0305","2038-3274"],"issn-type":[{"value":"2038-0305","type":"print"},{"value":"2038-3274","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,3]]},"assertion":[{"value":"10 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s next of kin for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal upon request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16"}}